Clinical High Risk for Psychosis (CHR) Clinical Trials in New York, New York
2 recruitingNew York, New York
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
Clinical High Risk for Psychosis (CHR)
Monument Therapeutics Limited150 enrolled15 locationsNCT07226895
Recruiting
Not Applicable
Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis
Clinical High Risk for Psychosis (CHR)
Icahn School of Medicine at Mount Sinai72 enrolled1 locationNCT05968560